Medscape |
Mepolizumab Relieves Severe Asthma, Trials Show
Medscape MUNICH, Germany — The monoclonal antibody mepolizumab delivered subcutaneously is a promising treatment for patients with severe eosinophilic asthma, according to the results of 2 new studies presented here at the European Respiratory Society … |
View full post on asthma – Google News